13-Aug-2026
Download PDF
Sudarshan Pharma
The Board of Directors at their meeting held on 12/August/2026 approved to acquire 3 000 equity shares (30.00% of paid up capital) of Sudarshan Maven Pharma Private Limited. Upon acqusition Sudarshan Maven Pharma Private Limited would become a wholly-owned subsidiary of the Company.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
